News About: Pharm. Industry
Choongwae’s parenteral nutrition products go to China
“Combiflex Lipid” and “non-PVC bag” are to be exported to China with the cooperation of Korea Health Industry Development Institute, local drugmaker Choongwae Pharma Corporation has announced on October 26.
The com...
Korean drug Agency OKs local trial of innovative osteoporosis drug
Helixer Co., a local biopharmaceutical company, said on October 26 that it has received approval from the Korean Food and Drug Administration to conduct Phase 3 clinical trial of a drug, PG201, for the treatment of os...
Korea’s leading drugmakers urged to attain 1 trillion sales within short period
This country’s leading pharmaceutical firms, such as Dong-A Pharm, Hanmi Pharm and Yuhan Corp., should surpass 1 trillion won in sales, which will lead to expansion of drug exports with renewed image of Korean pharmac...
Zuellig, multinationals blasted for hurting patients
Local pharmacists and doctors has recently accused Zuellig Pharma Korea (ZPK) and foreign-invested pharmaceutical firms of undermining patient benefits by exploiting their powerful market position, calling their busin...
Sibutramine 10 mg goes on sale
Ilsung Pharm says it has recently launched a low dose of generic Riductil (sibutamine 10 mg) capsules following the earlier release of its 17.56 mg capsules. The company terminated its Ruductil related agreement with ...
Pharmaceutical industry should be next growth engine
Korea needs to assess the damage that its free trade deals with other countries would cause in the local pharmaceutical industry in the future and map out proper countermeasures, including tax exemption on research an...
Novartis Korea, Dongwha to co-market Theraflu
Novartis Korea and Dongwha Pharm announced on October 21 that they have recently signed an agreement to co-market TheraFlu, a brand of over-the-counter cold and flu medicines that contain different groupings of variou...
Government to support Hanall’s R&D project for new drugs
Hanall Pharm said it will gear up its efforts to develop a novel combination drug containing losartan and amlodipine, backed by the government.
The combination product is based on Hanall’s platform technologies suc...
GSK releases PritorPlus 80/25 mg
GlaxoSmithKline (GSK) said it has recently launched a new antihypertensive agent Pritor Plus 80/25 (telmisartan 80 mg/hydrochlorothiazide 25 mg).
The combination product is indicated for the treatment of essential...
Dong-A looks to future with new drugs
The two drug candidates of Dong-A Pharmaceutical Co. are expected to bolster its stock prices in the near future, according to market analysts.
The company said that its pipeline drugs - functional dyspepsia drug (...
